Paper6736680
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Svennerholm AM and 5 others. J Infect Dis, 1984. Cited by 198 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. Papers, record 6736680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6736680
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Cholera | Major topic |
| Cholera Toxin | Major topic |
| Cholera Vaccines | Major topic |
| Intestinal Mucosa | Major topic |
| Vibrio cholerae | Major topic |
| Administration, Oral | |
| Adult | |
| Antitoxins | |
| Female | |
| Humans | |
| Immunoglobulin A | |
| Immunologic Memory | |
| Injections, Intramuscular | |
| Lipopolysaccharides | |
| Male | |
| Middle Aged | |
| Milk, Human | |
| Saliva | |
| Vaccination |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AI-16508 | NIAID NIH HHS | United States | R22AI016508 | PubMed and NIH |
Source NIH RePORTER
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 198 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,513,954 | ETVAX: From Concepts to Demonstrated Clinical Efficacy. | Microorganisms | 2026 | https://conductscience.org/library/papers/42513954 | PubMed |
| 36,196,193 | PRESIDENT'S ADDRESS: A LIFE WITH CHOLERA. | Trans Am Clin Climatol Assoc | 2022 | https://conductscience.org/library/papers/36196193 | PubMed |
| 34,453,544 | Modern History of Cholera Vaccines and the Pivotal Role of icddr,b. | J Infect Dis | 2021 | https://conductscience.org/library/papers/34453544 | PubMed |
| 33,925,118 | An Update on Cholera Immunity and Current and Future Cholera Vaccines. | Trop Med Infect Dis | 2021 | https://conductscience.org/library/papers/33925118 | PubMed |
| 33,879,588 | Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies. | mBio | 2021 | https://conductscience.org/library/papers/33879588 | PubMed |
| 31,206,533 | Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS). | PLoS One | 2019 | https://conductscience.org/library/papers/31206533 | PubMed |
| 30,845,262 | IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity. | PLoS One | 2019 | https://conductscience.org/library/papers/30845262 | PubMed |
| 29,214,494 | Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines. | J Microbiol | 2017 | https://conductscience.org/library/papers/29214494 | PubMed |
| 26,509,875 | Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction. | Mucosal Immunol | 2016 | https://conductscience.org/library/papers/26509875 | PubMed |
| 26,023,778 | An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/26023778 | PubMed |
| 25,179,492 | Rectal effluent as a research tool. | Dig Dis Sci | 2015 | https://conductscience.org/library/papers/25179492 | PubMed |
| 25,177,492 | Killed oral cholera vaccines: history, development and implementation challenges. | Ther Adv Vaccines | 2014 | https://conductscience.org/library/papers/25177492 | PubMed |
| 25,056,361 | Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. | Clin Vaccine Immunol | 2014 | https://conductscience.org/library/papers/25056361 | PubMed |
| 24,717,970 | Evaluation of anticoagulants for serologic assays of cholera vaccination. | Clin Vaccine Immunol | 2014 | https://conductscience.org/library/papers/24717970 | PubMed |
| 23,828,581 | Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23828581 | PubMed |
| 22,993,410 | Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. | Clin Vaccine Immunol | 2012 | https://conductscience.org/library/papers/22993410 | PubMed |
| 22,512,753 | Immune responses to cholera in children. | Expert Rev Anti Infect Ther | 2012 | https://conductscience.org/library/papers/22512753 | PubMed |
| 22,064,524 | New-generation vaccines against cholera. | Nat Rev Gastroenterol Hepatol | 2011 | https://conductscience.org/library/papers/22064524 | PubMed |
| 21,697,339 | Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans. | Clin Vaccine Immunol | 2011 | https://conductscience.org/library/papers/21697339 | PubMed |
| 21,415,493 | From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. | Indian J Med Res | 2011 | https://conductscience.org/library/papers/21415493 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6736680
GET https://conductscience.org/api/papers/v1/6736680/cited_by?page=2